Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.00
Bid: 150.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.667%)
Open: 155.00
High: 155.00
Low: 155.00
Prev. Close: 155.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil

Tue, 08th May 2018 07:01

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday following Monday's UK bank holiday as Chinese exports recovered at a faster pace in April amid concerns the US will re-impose sanctions on Iran.

IG futures indicate the FTSE 100 index is to open 45.80 points lower at 7578.80. The blue chip index closed up 0.9%, or 64.45 points, at 7,567.14 on Friday, ending the week 0.9% higher.

"Whilst Wall Street closed higher on the day, the real action was in the oil markets," said London Capital Group's Jasper Lawler.

"Oil extended gains from the European session into the start of the US session, easing back only after Trump announced a decision will be given [Tuesday] at 2pm EST over the Iranian nuclear pact."

Lawler added: "Oil has rallied hard on Venezuelan supply concerns and rising tensions between Iran and US. Repeated criticism from Trump over the US Iranian nuclear disarmament deal, has traders fearing that a withdrawal from Trump could see US sanctions being re-imposed on Iran."

"These sanctions would almost certainly include reductions to the country's oil exports, jolting the oil market and lifting the price of oil in recent sessions."

In the US on Monday, Wall Street ended up, with the Dow Jones Industrial Average 0.4% higher, S&P 500 up 0.4%, and Nasdaq Composite ending 0.8% up.

Crude oil prices reached a four-year high on Monday on the rising tensions between Iran and the US as President Donald Trump considers re-imposing sanctions on the country over its nuclear ambitions.

Oil was quoted at USD75.51 per barrel early on Tuesday.

The German and French foreign ministers on Monday in Berlin made a joint plea to Trump not to withdraw from the Iran nuclear deal.

"We fear that a failure would lead to escalations and that we would regress to the times before 2013," German Foreign Minister Heiko Maas said at a meeting with his counterpart Jean-Yves Le Drian.

Maas said that the world was safer with the agreement than without it and that the European signatories to the deal had prepared good recommendations for their US partners.

A May 12 deadline is looming for the US president to decide whether to continue backing the 2015 nuclear deal with Iran or reimpose sanctions on Tehran, which would mean scrapping the Joint Comprehensive Plan of Action (JPCOA), as the deal is known officially.

The deal - sealed by Trump's predecessor Barack Obama with the support of China, Russia, Germany, France and Britain - eased sanctions on Tehran in exchange for commitments to abandon its nuclear weapons programme.

Earlier Monday, British Foreign Secretary Boris Johnson used an opinion piece in the to pressure Trump over the deal.

"At this delicate juncture, it would be a mistake to walk away from the nuclear agreement and remove the restraints that it places on Iran," Johnson wrote.

The Japanese Nikkei 225 index is 0.1% higher early Tuesday. In China, the Shanghai Composite is up 0.8%, while the Hang Seng index in Hong Kong is up 1.3%.

China's exports recovered at a faster than expected pace in April and imports growth accelerated notably, data from General Administration of Customs revealed Tuesday.

Exports advanced 13% year-on-year in April, reversing a 2.7% drop in March. Economists had forecast an increase of 8%.

At the same time, imports growth accelerated to 21.5% from 14.4% in the previous month. Imports were expected to rise 16%.

Consequently, the trade surplus totalled USD28.8 billion in April, above the expected level of USD27.75 billion.

In yuan terms, shipments gained 3.7% and imports logged a faster growth of 12% in April.

In the UK corporate calendar on Tuesday there are trading statements from bookmaker William Hill and insurer Hiscox, full-year results from Horizon Discovery Group and Faron Pharmaceuticals, and first quarter figures from Verona Pharmaceuticals.

To come in the economic calendar on Tuesday, in the afternoon in the US the Redbook index is due at 1355 BST, with JOLTS job openings at 1500 BST.

More News
3 May 2024 13:39

TRADING UPDATES: Kelso raises stake in NCC; Transense joins project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

Read more
30 Apr 2024 16:33

Faron Pharmaceuticals extends funding agreement with IPF

(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support as it progressed towards securing longer-term funding.

Read more
15 Apr 2024 10:58

Faron Pharmaceuticals reappoints former finance chief on interim basis

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien.

Read more
15 Apr 2024 09:36

Faron Pharmaceuticals CFO stands down

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".

Read more
8 Apr 2024 11:50

UPDATE: Faron Pharmaceuticals promotes COO to CEO as father retires

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace his father, the company's founder.

Read more
8 Apr 2024 11:28

Faron Pharmaceuticals promotes COO to CEO as founder steps back

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace the company's founder.

Read more
8 Apr 2024 09:17

Faron Pharmaceuticals taps Juho Jalkanen for CEO

(Sharecast News) - Biopharmaceutical company Faron Pharmaceuticals named Dr Juho Jalkanen as its next chief executive officer on Monday.

Read more
4 Apr 2024 11:58

Faron Pharmaceuticals secures funding to deliver next "milestones"

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has successfully raised funds to support the phase two study of its bexmarilimab cancer treatment.

Read more
3 Apr 2024 10:59

TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Apr 2024 13:22

UK shareholder meetings calendar - next 7 days

Wednesday 3 April 
Downing Strategic Micro-Cap Investment Trust PLCGM re approval of B share scheme
Quantum Exponential Group PLCGM re delisting or potential investment in company
Thursday 4 April 
Rio Tinto PLCAGM
Scottish American Investment Co PLCAGM
TheWorks.co.uk PLCGM re Main Market delisting and AIM admission
Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 17:09

LONDON MARKET CLOSE: Stocks downbeat before central bank rate storm

(Alliance News) - Stocks in London closed in the red on Monday, as tech gains in New York failed to make an impact ahead of several interest rate decisions from central banks across the world this week.

Read more
18 Mar 2024 14:14

Faron shares jump on encouraging trial data

(Sharecast News) - Faron Pharmaceuticals announced further encouraging data from the first phase of its 'BEXMAB' trial on Monday, targeting higher-risk (HR) myelodysplastic syndrome (MDS) patients who had failed prior hypomethylating agent (HMA) treatment.

Read more
18 Mar 2024 11:41

Faron Pharmaceuticals shares jump on positive data from Bexmab study

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said a study showed more patients responding to treatment in a new readout of the Bexmab study focused on myelodysplastic syndrome, or MDS.

Read more
18 Mar 2024 10:05

AIM WINNERS & LOSERS: Clontarf raises GBP400,000; Faron jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.